GSK’s new beta-blocker to be released in domestic hypertensive drug market
Holding the launching symposium, GSK has signed an agreement with Italy based Mylan Laboratories to distribute Nebilet in Korea.
Nebivolol is a selecti...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
